Abstract
Thirty percent of individuals with chromosome 22q11.2 deletion syndrome (22q11.2DS) develop a psychotic disorder, particularly schizophrenia. We assessed attenuated positive, negative and disorganized symptoms of psychosis and clinical-high-risk syndromes in 20 adolescents with 22q11.2DS (median age 15.1. years) using the Structured Interview for Prodromal Symptoms (SIPS). Two participants met criteria for the Attenuated Positive Symptom Syndrome, while nine participants (45%) experienced positive symptoms rated in the "moderate" to "severe and psychotic" range on the SIPS. Almost all presented with moderate to severe symptoms in the negative, disorganized, and general symptom domains.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 118-121 |
| Number of pages | 4 |
| Journal | Schizophrenia Research |
| Volume | 118 |
| Issue number | 1-3 |
| DOIs | |
| State | Published - May 2010 |
Keywords
- Chromosome 22q11.2 deletion syndrome
- Clinical-high-risk psychosis
- Prodromal psychosis
- Schizophrenia
- VCFS
ASJC Scopus subject areas
- Psychiatry and Mental health
- Biological Psychiatry
Fingerprint Dive into the research topics of 'Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome'. Together they form a unique fingerprint.
Cite this
Stoddard, J., Niendam, T. A., Hendren, R., Carter, C. S., & Simon, T. J. (2010). Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophrenia Research, 118(1-3), 118-121. https://doi.org/10.1016/j.schres.2009.12.011